Introduction: There is insufficient evidence on the efficacy and safety of pharmacological cardioversion of recent-onset atrial fibrillation (AF) in elderly patients. Antazoline has been shown to be ...

A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial ...

Non-vitamin K antagonist oral anticoagulants (NOACs) have proven a favorable risk-benefit profile compared to vitamin K antagonists (VKAs) for preventing stroke and systemic embolism in patients with ...

Sweden: Researchers have found in a new study that pre-cardioversion rhythm monitoring using smartphone-based ...

However, several factors confound the role of inflammation in generation and perpetuation of AF. As an example, failure to show a correlation between baseline hsCRP levels and maintenance of sinus ...

The 2006 American College of Cardiology/American Heart Association/European Society of Cardiology (ACC/AHA/ESC) Practice Guidelines for the Management of Atrial Fibrillation state that various benign ...

Heart rhythm monitoring in the weeks before cardioversion therapy for atrial fibrillation/atrial flutter reduced the ...

BARCELONA -- Cardiologists who have switched atrial fibrillation patients awaiting elective cardioversion to a novel oral anticoagulant (NOAC) such as rivaroxaban (Xarelto) may find reassurance in the ...

"Due to the risk of thromboembolism, clinical guidelines recommend anticoagulation before and after cardioversion in patients with atrial fibrillation," said Andreas Goette, MD, Chief Physician, St.

Atrial fibrillation (AF or afib) involves abnormal electrical activity in the upper chambers (atria) of your heart, which causes the organ to beat quickly and irregularly. This abnormal beating ...

This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major ...

A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial ...